ABBOTT LABORATORIES EPS (Diluted) 2007-2025 | ABT
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is ABBOTT LABORATORIES's current eps (diluted)?
ABBOTT LABORATORIES (ABT) annual eps (diluted) for 2024 was $7.64, a 134.36% increase from 2023. ABBOTT LABORATORIES eps (diluted) for the quarter ending September 30, 2025 was $0.94.
What was ABBOTT LABORATORIES's eps (diluted) in 2023?
ABBOTT LABORATORIES annual eps (diluted) for 2023 was $3.26, a 16.62% decline from 2022.
What was ABBOTT LABORATORIES's eps (diluted) in 2022?
ABBOTT LABORATORIES annual eps (diluted) for 2022 was $3.91, a 0.76% decline from 2021.
What is ABBOTT LABORATORIES's 5-year eps (diluted) CAGR?
ABBOTT LABORATORIES eps (diluted) grew at a compound annual growth rate (CAGR) of 29.97% from FY2019 to FY2024, going from $2.06 to $7.64 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $7.64 | +134.4% | 10-K |
| FY2023 | $3.26 | -16.6% | 10-K |
| FY2022 | $3.91 | -0.8% | 10-K |
| FY2021 | $3.94 | +57.6% | 10-K |
| FY2020 | $2.50 | +21.4% | 10-K |
| FY2019 | $2.06 | +54.9% | 10-K |
| FY2018 | $1.33 | +392.6% | 10-K |
| FY2017 | $0.27 | -71.3% | 10-K |
| FY2016 | $0.94 | -67.8% | 10-K |
| FY2015 | $2.92 | +96.0% | 10-K |
| FY2014 | $1.49 | -8.0% | 10-K |
| FY2013 | $1.62 | -56.5% | 10-K |
| FY2012 | $3.72 | +23.6% | 10-K |
| FY2011 | $3.01 | +1.7% | 10-K |
| FY2010 | $2.96 | -19.8% | 10-K |
| FY2009 | $3.69 | +18.3% | 10-K |
| FY2008 | $3.12 | +35.1% | 10-K |
| FY2007 | $2.31 | - | 10-K |